RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Patricia K. Coyle, MD, FAAN, FANA Professor and Interim Chair Director, MS Comprehensive Care Center Stony Brook University Medical Center Stony Brook, New York PROGRAM OVERVIEW This activity will cover the treatment and management of patients with multiple sclerosis (MS). TARGET AUDIENCE This activity is designed …
Author Archives: Jenn Pichardo
The Role of Neurologists and Neuroophthalmologists in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder
RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Brian G. Weinshenker, MD, FRCP(C) Consultant, Department of Neurology Professor of Neurology, College of Medicine Mayo Clinic Rochester, MN PROGRAM OVERVIEW This case-based activity will cover the treatment and management of patients with NMOSD. TARGET AUDIENCE This activity is designed to meet the educational needs of …
Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies
Wednesday, June 24, 2020 7:00 pm (ET) SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies TARGET AUDIENCE This activity has been designed to meet the educational needs of physicians, PAs, nursing professionals, and other …
Continue reading “Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies”
Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis
Thursday, June 25th, 2020 7:00 – 8:30 pm (ET) AGENDA I. Why We Need New Approaches to Treating MS – Fred D. Lublin, MD II. The Science of BTK Inhibitors: Adaptive and Innate Immunity – Benjamin M. Greenberg, MD, MHS III. A Clinical Trial Review and Analysis on the Safety and Efficacy of Novel BTK …
The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis
RELEASE DATE: June 1, 2020 EXPIRATION DATE: June 1, 2021 TARGET AUDIENCE This activity is designed to meet the educational needs of physicians, nurses, advanced practice clinicians, and pharmacists who manage patients with multiple sclerosis (MS). PROGRAM DESCRIPTION Asymptomatic or subclinical progression occurs in all stages of multiple sclerosis (MS) and should be part of treatment decisions, …
Continue reading “The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis”
IJMSC: Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis
RELEASE DATE: June 1, 2020 EXPIRATION DATE: June 1, 2021 TARGET AUDIENCEThe target audience for this activity is physicians, physician assistants, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS). LEARNING OBJECTIVES Differentiate between measurement tools for clinical walking capacity and for real-world performance. Describe discrepancies between performance on …
Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS
RELEASE DATE: June 8, 2020 EXPIRATION DATE: June 8, 2021 THIS ACTIVITY OFFERS CE CREDIT FOR: Physicians (CME) Nurses (CNE) Pharmacists (ACPE) ABIM (MOC) Other All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™ FACULTY Fred D. Lublin, MD, FAAN, FANA Saunders Family Professor of …
A Clinician’s Guide to Cognition in MS
A Clinician’s Guide to Cognition in MSSarah Morrow, MD, MS, FRCPC, FAAN RELEASE DATE: May 29, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, …
The Role of Biological Aging In MS Progression
The Role of Biological Aging In MS ProgressionJennifer Graves, MD, PhD, MAS RELEASE DATE: May 29, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, …
Continue reading “The Role of Biological Aging In MS Progression”
Use of Psychotropics in MS: Antidepressants, Antianxiety Agents, Mood Stabilizers, Hypnotics, Antipsychotics, and Cognitive Enhancers
Use of Psychotropics in MS: Antidepressants, Antianxiety Agents, Mood Stabilizers, Hypnotics, Antipsychotics, and Cognitive EnhancersLaura Safar, MD RELEASE DATE: May 28, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social …